abnormal fibroblast proliferation, abnormal gas homeostasis, abnormal glial cell apoptosis, abnormal glial cell physiology, abnormal hepatocyte morphology, abnormal interleukin level, abnormal intestinal goblet cell morphology, abnormal level of surface class II molecules, abnormal lipid level, abnormal locomotor behavior, abnormal macrophage chemotaxis, abnormal macrophage physiology, abnormal microglial cell physiology, abnormal muscle cell glucose uptake, abnormal myelin sheath morphology, abnormal nephron morphology, abnormal neuron differentiation, abnormal osteoclast differentiation, abnormal phagocyte morphology, abnormal proximal convoluted tubule brush border morphology, abnormal pulmonary alveolar duct morphology, abnormal pulmonary alveolus morphology, abnormal pulmonary elastic fiber morphology, abnormal renal tubule epithelium morphology, abnormal renal tubule morphology, abnormal retina layer morphology, abnormal retina pigment epithelium morphology, abnormal retina progenitor cell morphology, abnormal retina rod bipolar cell morphology, abnormal retina rod cell morphology, abnormal spleen weight, abnormal susceptibility to infection, abnormal tumor necrosis factor level, abnormal vascular wound healing, brain ischemia, cellular necrosis, decreased B cell proliferation, decreased acute inflammation, decreased angiogenesis, decreased body size, decreased cerebral infarct size, decreased circulating alanine transaminase level, decreased circulating interleukin-6 level, decreased epididymal fat pad weight, decreased fat cell size, decreased heart weight, decreased hemoglobin content, decreased hepatocyte apoptosis, decreased incidence of tumors by chemical induction, decreased interferon-beta secretion, decreased interleukin-1 beta secretion, decreased interleukin-10 secretion, decreased interleukin-6 secretion, decreased liver triglyceride level, decreased macrophage apoptosis, decreased macrophage cytokine production, decreased memory B cell number, decreased neuron apoptosis, decreased percent body fat/body weight, decreased respiratory quotient, decreased response of heart to induced stress, decreased sensitivity to induced morbidity/mortality, decreased susceptibility to Orthomyxoviridae infection, decreased susceptibility to bacterial infection, decreased susceptibility to bone fracture, decreased susceptibility to endotoxin shock, decreased susceptibility to induced arthritis, decreased susceptibility to injury, decreased susceptibility to ischemic brain injury, decreased susceptibility to kidney reperfusion injury, decreased susceptibility to weight loss, decreased tumor necrosis factor secretion, digestive/alimentary phenotype, dilated pulmonary alveolar duct, dilated renal tubules, enlarged cecum, enlarged lung, enlarged mesenteric lymph nodes, focal hepatic necrosis, hearing/vestibular/ear phenotype, hematopoietic system phenotype, homeostasis/metabolism phenotype, hyporesponsive to tactile stimuli, immune system phenotype, improved glucose tolerance, increased bone mass, increased bone mineral content, increased cell death, increased circulating interleukin-6 level, increased lung compliance, increased oxygen consumption, increased spleen weight, increased susceptibility to Poxviridae infection induced morbidity/mortality, increased susceptibility to induced arthritis, increased thermal nociceptive threshold, muscle phenotype, no abnormal phenotype detected, renal cast, respiratory system phenotype, small superior vagus ganglion